
|Articles|February 18, 2022
Daily Medication Pearl: Vortioxetine (Trintellix)
Author(s)Saro Arakelians, PharmD
Vortioxetine (Trintellix) treats major depressive disorder in adults.
Advertisement
Medication Pearl of the Day: Vortioxetine (Trintellix)
Indication: Trintellix is indicated for the treatment of major depressive disorder in adults.
Insight:
- Dosing: The recommended starting dose is 10 mg administered orally once daily without regard to meals
- Dosage forms: Tablets 5 mg, 10 mg, and 20 mg.
- Adverse events: Most common adverse reactions (incidence ≥5% and at least twice the rate of placebo) were nausea, constipation, and vomiting.
- Mechanism of action: The mechanism of the antidepressant effect of vortioxetine is not fully understood, but is thought to be related to its enhancement of serotonergic activity in the CNS through inhibition of the reuptake of serotonin.
- Manufacturer: Takeda Pharma
Sources:
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Staging the Heart: NLA and EAS Reveal a New Era of Precision Lipidology and Imaging
2
Orforglipron Reduces Body Weight Up to 14% in Women at Every Stage of Menopause
3
Final CLL14 Analysis Confirms Durable Benefit With Fixed-Duration Venetoclax-Obinutuzumab in Frontline CLL
4
New Evidence Positions Finerenone as Foundational Therapy Across the CKD Spectrum
5


































































































































